Results 71 to 80 of about 412,268 (100)

<i>CDKN2A</i> mRNA Over-expression Is Associated With CD8+ T Cell Exclusion and IDO1-Mediated Adaptive Immune Resistance in Gastric Adenocarcinoma. [PDF]

Cancer Diagn Progn
Lehrer S, Rheinstein P.
europepmc   +1 more source

Longitudinal single-cell and TCR repertoire profiling characterizes clonal entrapment in patients with pMMR/MSS locally advanced rectal cancer. [PDF]

Cell Discov
Tang Z, Zhu M, Zhao S, Pang D, Cui Y, Lin G, Wu A, Lin Y, Jiang X, Zhang W, Xiong N, Yang C, Wang C, Wang S, Ye Y, Bai F, Shen Z.   +16 more
europepmc   +1 more source

Evaluating the effects of CD8/CD4 on T cell function in terms of TCR-pMHC-coreceptor catch and slip bonds. [PDF]

Front Immunol
Travaglino S, Kazemipour Ashkezari AH, Li M, Watson VE, Cong P, Doudy L, Choi HK, Zhu C.   +7 more
europepmc   +1 more source

Hyperglycemia aggravates vitiligo through succinate/SUCNR1-mediated T cell activation. [PDF]

J Clin Invest
Kang P, Chang Y, Wang T, Yi X, Wang Y, Du P, Chen J, Li B, Li S, Shao Z, Chen J, Li C.   +11 more
europepmc   +1 more source

HLA-G expression in non-small cell lung cancer: prognostic significance and interplay with PD-L1 and CD8⁺ tumor-infiltrating lymphocytes. [PDF]

Front Immunol
Querzoli G, Bogina G, Marconi M, Tumino N, Vacca P, Righi L, Pilotto S, Caliò A, Cima L, Gobbo S, Cecchini MJ, Paolino G, Ciompi F, Accolla RS, Scarpa A, Lunardi G, Marcenaro E, Moretta L, Zamboni G, Munari E.   +19 more
europepmc   +1 more source

Target receptor expression dictates the selective intra-tumoral targeting of CD8⁺ T cells by eciskafusp alfa in matched PBMCs and TILs from CPI-naïve patients. [PDF]

Front Immunol
Manchala A, Varypataki EM, Charo J, Umaña P, Klein C, Codarri Deak L.   +5 more
europepmc   +1 more source

Cell-autonomous co-stimulatory function of membrane-bound CD100 promotes activation and differentiation of HBcAg-specific CD8⁺ T cells. [PDF]

Front Immunol
Zhao M, Chen L, Chen Y, Wang L, Yang X, Sutter K, Lu M, Chen J, Zheng X, Yang D, Wang L, Liu J.   +11 more
europepmc   +1 more source

Targeting tumor-specific T cells with LAG3-directed interleukin-2 prevents T-cell exhaustion and reinvigorates antitumor immunity. [PDF]

Signal Transduct Target Ther
Yu X, Liao H, Lv J, Sun Y, Zhang R, Chen Y, Lin Y, Liu L, Li S, Tang H, Jia P, Shao B, Yang Z, Fu YX, Ren Z.   +14 more
europepmc   +1 more source

PD-1⁺CD8⁺ T cell infiltration complements PD-L1 to predict first-line chemo-immunotherapy outcomes in advanced ESCC. [PDF]

Biomark Res
Zhao Q, Cheng S, Meng Y, Li B, Wang L.
europepmc   +1 more source

CD11c+ CD8 T cells cause IFN-γ-dependent autoimmune neuroinflammation that is restrained by PD-1 signaling. [PDF]

JCI Insight
Hwang D, Azizi G, Ishikawa LLW, Seyedsadr M, Cox A, Jang S, Kasimoglu E, Rostami A, Zhang GX, Ciric B.   +9 more
europepmc   +1 more source